The SETX Gene Amyotrophic Lateral Sclerosis Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the SETX gene, which are associated with Amyotrophic Lateral Sclerosis (ALS) Type 4. ALS Type 4 is a rare hereditary form of the disease characterized by a slower progression compared to other types of ALS. The test plays a crucial role in early diagnosis, enabling targeted interventions and informed family planning decisions. Priced at 4400 AED, this genetic test involves analyzing the patient's DNA to detect specific genetic alterations in the SETX gene, providing valuable insights into the patient's condition and risk factors. DNA Labs UAE, known for its state-of-the-art facilities and expert genetic counseling, ensures a comprehensive support system for individuals undergoing this test.
The FUS Gene Amyotrophic Lateral Sclerosis Type 6 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the FUS gene, which are associated with the development of Amyotrophic Lateral Sclerosis (ALS) type 6. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability. The FUS gene plays a critical role in the functioning of neurons, and mutations in this gene can lead to the familial form of ALS, which accounts for a small percentage of ALS cases.
This test is particularly important for individuals with a family history of ALS or those who have been diagnosed with ALS and are seeking a genetic explanation for their condition. By identifying the presence of FUS gene mutations, the test can provide crucial information for the diagnosis, prognosis, and potential treatment options for patients and their families. It can also aid in genetic counseling for family members who may be at risk.
The cost of the FUS Gene Amyotrophic Lateral Sclerosis Type 6 Genetic Test at DNA Labs UAE is 4400 AED. The test is conducted using a sample of the patient's blood or saliva, which is then analyzed in the laboratory for the presence of genetic mutations in the FUS gene. The results of this test can have significant implications for the management and understanding of ALS, making it a valuable tool in the fight against this challenging condition.
The VAPB Gene Amyotrophic Lateral Sclerosis type 8 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the VAPB gene, which have been associated with a rare form of Amyotrophic Lateral Sclerosis (ALS), also known as ALS type 8. This condition is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. By examining a patient's DNA sample, usually obtained through a blood draw, the test can pinpoint specific genetic alterations in the VAPB gene that are indicative of ALS type 8. This information is crucial for early diagnosis, allowing for better management of the condition and counseling for affected individuals and their families.
The cost of the VAPB Gene Amyotrophic Lateral Sclerosis type 8 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full analysis and a comprehensive report that details the findings. Given the complexity of genetic testing and the specialized technology required, the cost reflects the extensive resources involved in providing accurate and reliable results.
The ANG Gene Amyotrophic Lateral Sclerosis Type 9 Genetic Test is a specialized diagnostic tool used to identify mutations in the ANG gene, which are linked to the development of Amyotrophic Lateral Sclerosis (ALS) type 9. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord, leading to muscle weakness and, eventually, severe physical disability. The test is particularly valuable for individuals with a family history of ALS or those showing symptoms of the disease, as it can provide crucial information for early diagnosis and management.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific mutations in the ANG gene. These mutations can indicate a person's susceptibility to developing ALS type 9, allowing for early interventions and informed decisions regarding health and lifestyle.
The cost of the ANG Gene Amyotrophic Lateral Sclerosis Type 9 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides for affected individuals and their families cannot be understated. It opens the door to genetic counseling, personalized treatment plans, and, in some cases, participation in clinical trials for novel therapies, significantly impacting the quality of life and disease management for those with or at risk of ALS type 9.
The C9orf72 gene test for Amyotrophic Lateral Sclerosis (ALS) with Frontotemporal Dementia (FTD) is a specialized genetic test available at DNA Labs UAE, designed to identify expansions in the C9orf72 gene, which are known to be the most common genetic cause of both familial ALS and FTD. This test is crucial for individuals with a family history of these conditions or those exhibiting symptoms, as it aids in the accurate diagnosis and understanding of their risk of developing these neurodegenerative diseases. The test is performed with a high degree of accuracy and confidentiality, ensuring patients receive comprehensive support and information. The cost of the C9orf72 gene test at DNA Labs UAE is 4400 AED, reflecting the sophisticated technology and expertise required to conduct this analysis.
The SS18L1 gene has been implicated in a range of neurological conditions, including Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. The genetic test focusing on the SS18L1 gene's involvement in ALS, particularly in relation to the CREST syndrome - a complex disorder that can include calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia - provides crucial insights for individuals with a family history of ALS or related symptoms.
DNA Labs UAE offers a specialized genetic test targeting the SS18L1 gene to identify mutations that may contribute to the development of ALS and its overlap with CREST-related symptoms. This test is essential for patients seeking a comprehensive understanding of their genetic predisposition to ALS and CREST syndrome, allowing for early intervention, personalized treatment plans, and informed family planning.
The cost of this comprehensive genetic test is 4400 AED. Conducted at DNA Labs UAE, the test involves a simple procedure but offers profound insights into the patient's genetic makeup, potentially guiding crucial health decisions and lifestyle adjustments to manage or mitigate the risk of ALS and related conditions.
The NEFH gene, known for its role in encoding the heavy neurofilament protein, has been linked to susceptibility to Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease affecting nerve cells in the brain and the spinal cord. Genetic testing focused on the NEFH gene can provide crucial insights into an individual's risk of developing ALS, allowing for early intervention and personalized management strategies.
At DNA Labs UAE, a specialized test is available to assess the genetic variations in the NEFH gene that might increase susceptibility to ALS. The test, priced at 4400 AED, involves a comprehensive analysis of the NEFH gene to identify mutations that could indicate a higher risk of developing this debilitating condition. By opting for this genetic test, individuals can gain valuable information about their genetic predisposition to ALS, enabling them to make informed decisions about their health and future.
The VPS54 gene has been identified as a potential contributor to the development of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. The VPS54-related genetic test is a specialized diagnostic tool designed to detect mutations in the VPS54 gene, which may indicate an increased risk or presence of ALS in individuals. This test is particularly useful for those with a family history of ALS or related symptoms, providing crucial information for early diagnosis and potential management of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the VPS54 gene test is performed with high precision and accuracy. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise involved in conducting the analysis. By opting for this test, individuals can gain valuable insights into their genetic predisposition towards ALS, enabling them to make informed decisions regarding their health and future care plans.
The APP Gene Alzheimer Disease Type 1 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the APP gene, which are strongly linked to the early onset of Alzheimer's disease. Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. The APP gene encodes the amyloid precursor protein, and mutations in this gene can lead to the abnormal accumulation of amyloid-beta peptides in the brain, a hallmark of Alzheimer's disease.
This genetic test is particularly important for individuals with a family history of early-onset Alzheimer's disease, as it can provide crucial information regarding their risk of developing the condition. Early detection through genetic testing allows for timely intervention and management strategies to slow the progression of the disease and improve the quality of life for affected individuals.
The test is conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing services. The cost of the APP Gene Alzheimer Disease Type 1 Genetic Test is 4400 AED. The testing process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the APP gene. The results of this test can guide healthcare professionals in developing personalized care plans for individuals at risk or affected by Alzheimer's disease, focusing on managing symptoms and providing support for the patient and their family.
The NOS3 gene, also known as the endothelial nitric oxide synthase (eNOS) gene, plays a crucial role in vascular function and has been implicated in various cardiovascular diseases. Recent studies suggest that variations in the NOS3 gene may also be linked to Alzheimer's disease type 1, a neurodegenerative disorder characterized by progressive memory loss, cognitive decline, and behavioral changes. The association is thought to be due to the gene's impact on blood flow and nutrient delivery to the brain, influencing the development and progression of Alzheimer's disease.
To explore this genetic link further, DNA Labs UAE offers a specialized genetic test targeting the NOS3 gene in relation to Alzheimer's disease type 1. This test is designed to identify specific mutations or variations within the NOS3 gene that may increase an individual's risk of developing Alzheimer's disease. By analyzing a sample of the patient's DNA, the test can provide valuable insights into their genetic predisposition to this condition.
The cost of the NOS3 Gene Alzheimer Disease Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full testing procedure, from sample collection to detailed analysis and reporting. Patients who opt for this test can expect a comprehensive evaluation of their genetic risk factors for Alzheimer's disease, enabling them to make informed decisions about their health and potential preventive measures. It's an essential tool for those with a family history of Alzheimer's disease or individuals seeking to understand their genetic health profile better.
